CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Financials Charles River Laboratories International, Inc.

Equities

CRL

US1598641074

Biotechnology & Medical Research

Market Closed - Nyse Other stock markets 21:00:02 21/05/2025 BST			5-day change	1st Jan Change
134.98 ^USD	-5.96%		-2.86%	-26.88%

05-14	Charles River Laboratories International, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 08:40 AM
05-14	TD Cowen Upgrades Charles River Laboratories International to Buy From Hold, Adjusts PT to $179 From $105	MT

Projected Income Statement: Charles River Laboratories International, Inc.

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net sales ¹	2,924	3,540	3,976	4,129	4,050	3,883	3,963	4,084
Change	-	21.08%	12.31%	3.86%	-1.92%	-4.13%	2.07%	3.06%
EBITDA ¹	701.3	879.5	990.9	1,013	996.1	946.9	979.8	1,049
Change	-	25.4%	12.67%	2.26%	-1.7%	-4.95%	3.48%	7.03%
EBIT ¹	585	742.1	834	838.8	805.9	752.3	792.8	846.1
Change	-	26.85%	12.39%	0.58%	-3.92%	-6.66%	5.38%	6.73%
Interest Paid ¹	-86.43	-73.91	-59.29	-136.7	-126.3	-113.3	-116.5	-114.6
Earnings before Tax (EBT) ¹	447.1	480.7	623	581.3	93.11	336	381.3	420.2
Change	-	7.51%	29.6%	-6.69%	-83.98%	260.85%	13.49%	10.21%
Net income ¹	364.3	391	486.2	474.6	10.3	222	286.1	328.6
Change	-	7.32%	24.36%	-2.39%	-97.83%	2,056.23%	28.88%	14.83%
Announcement Date	17/02/21	16/02/22	22/02/23	14/02/24	19/02/25	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1
Net sales ¹	682.6	743.3	791	824.6	914.6	895.9	905	913.9	973.1	989.2	1,100	1,029	1,060	1,027	1,013	1,012	1,026	1,010	1,003	984.2	983.8	960	964.1	993.9	998.8	982.7	992	1,029
Change	-	8.9%	6.42%	4.24%	10.92%	-2.04%	1.02%	0.98%	6.48%	1.65%	11.19%	-6.41%	2.97%	-3.14%	-1.28%	-0.19%	1.44%	-1.59%	-0.71%	-1.83%	-0.04%	-2.42%	0.43%	3.09%	0.5%	-1.61%	0.95%	3.73%
EBITDA ¹	143.7	199.8	197.5	202.3	223.9	226.3	226.9	233.2	250.4	240.4	266.9	259.8	259.5	255.4	238.5	233.1	266.2	248.9	247.9	385.5	240.1	234.5	236.1	242.8	244.4	241.4	244.6	255.6
Change	-	39.04%	-1.17%	2.45%	10.7%	1.05%	0.29%	2.77%	7.37%	-4.01%	11.01%	-2.63%	-0.13%	-1.57%	-6.61%	-2.28%	14.21%	-6.49%	-0.42%	55.52%	-37.72%	-2.33%	0.67%	2.83%	0.68%	-1.25%	1.33%	4.5%
EBIT ¹	117.8	168.6	164.7	171	190.2	191.8	189.1	196	211.7	201.4	224.8	217.8	216.2	210.9	193.9	187.4	218.6	200.4	199.5	188.2	194.1	184.2	185.3	193.8	199.3	193.7	191.8	203.4
Change	-	43.15%	-2.31%	3.83%	11.22%	0.87%	-1.42%	3.66%	7.99%	-4.86%	11.63%	-3.14%	-0.73%	-2.46%	-8.03%	-3.37%	16.61%	-8.29%	-0.46%	-5.67%	3.12%	-5.11%	0.59%	4.59%	2.88%	-2.83%	-0.98%	6.02%
Charge d'intérêts ¹	-19.35	-18.87	-33.15	-29.72	-16.19	-16.46	-11.55	-9.434	-3.703	-11.38	-34.78	-34.38	-35.04	-33.74	-33.54	-35	-32.77	-30.28	-28.23	-27.88	-28.38	-28.49	-28.33	-28.92	-28.84	-28.77	-28.69	-28.61
Earnings before Tax (EBT)	83.95	135.3	172.4	66.3	127.5	123.3	163.6	110.8	144.1	123.1	244.9	131	128.7	112.9	208.7	99.01	119.7	91.24	-216.8	-	-	-	-	-	-	-	-	-
Change	-	61.13%	27.46%	-61.55%	92.3%	-3.31%	32.75%	-32.26%	30.01%	-14.58%	98.95%	-46.5%	-1.81%	-12.27%	84.9%	-52.56%	20.85%	-23.75%	-337.6%	-	-	-	-	-	-	-	-	-
Net income ¹	67.44	102.9	143.2	61.53	88.45	103.4	137.6	93.02	109.3	96.47	187.4	103.1	97.02	87.39	187.1	67.33	89.99	68.68	-215.7	25.47	52.62	53.95	56.86	59.8	59.72	75.78	75.97	84.32
Change	-	52.6%	39.14%	-57.03%	43.75%	16.93%	33.02%	-32.39%	17.52%	-11.75%	94.26%	-44.97%	-5.93%	-9.93%	114.08%	-64.01%	33.65%	-23.68%	-414.07%	111.81%	106.62%	2.51%	5.4%	5.18%	-0.13%	26.88%	0.26%	10.98%
Announcement Date	05/08/20	29/10/20	17/02/21	04/05/21	04/08/21	03/11/21	16/02/22	04/05/22	03/08/22	02/11/22	22/02/23	11/05/23	09/08/23	08/11/23	14/02/24	09/05/24	07/08/24	06/11/24	19/02/25	07/05/25	-	-	-	-	-	-	-	-

¹USD in Million

Estimates

Forecast Balance Sheet: Charles River Laboratories International, Inc.

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net Debt ¹	1,751	2,425	2,477	2,370	2,046	2,173	1,785	1,600
Change	-	38.49%	2.14%	-4.32%	-13.67%	6.23%	-17.86%	-10.36%
Announcement Date	17/02/21	16/02/22	22/02/23	14/02/24	19/02/25	-	-	-

¹USD in Million

Estimates

Cash Flow Forecast: Charles River Laboratories International, Inc.

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
CAPEX ¹	166.6	228.8	324.7	318.5	233	238.7	236	264.5
Change	-	37.35%	41.95%	-1.91%	-26.86%	2.45%	-1.12%	12.05%
Free Cash Flow (FCF) ¹	380	532	294.9	365.4	501.6	369.1	418.3	447.6
Change	-	40%	-44.57%	23.89%	37.29%	-26.43%	13.34%	7%
Announcement Date	17/02/21	16/02/22	22/02/23	14/02/24	19/02/25	-	-	-

¹USD in Million

Estimates

Forecast Financial Ratios: Charles River Laboratories International, Inc.

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Profitability
EBITDA Margin (%)	23.99%	24.84%	24.92%	24.54%	24.6%	24.39%	24.72%	25.68%
EBIT Margin (%)	20.01%	20.96%	20.97%	20.31%	19.9%	19.38%	20%	20.72%
EBT Margin (%)	15.29%	13.58%	15.67%	14.08%	2.3%	8.65%	9.62%	10.29%
Net margin (%)	12.46%	11.04%	12.23%	11.49%	0.25%	5.72%	7.22%	8.04%
FCF margin (%)	13%	15.03%	7.42%	8.85%	12.39%	9.51%	10.55%	10.96%
FCF / Net Income (%)	104.31%	136.07%	60.65%	76.98%	4,871.42%	166.22%	146.18%	136.21%
Profitability
ROA	8.08%	8.48%	7.8%	6.95%	6.78%	5.25%	5.56%	5.79%
ROE	21.95%	22.82%	20.71%	16.7%	15.1%	14.07%	15.13%	15.38%
Financial Health
Leverage (Debt/EBITDA)	2.5x	2.76x	2.5x	2.34x	2.05x	2.29x	1.82x	1.53x
Debt / Free cash flow	4.61x	4.56x	8.4x	6.49x	4.08x	5.89x	4.27x	3.57x
Capital Intensity
CAPEX / Current Assets (%)	5.7%	6.46%	8.17%	7.71%	5.75%	6.15%	5.96%	6.47%
CAPEX / EBITDA (%)	23.75%	26.01%	32.77%	31.43%	23.39%	25.21%	24.09%	25.22%
CAPEX / FCF (%)	43.83%	43%	110.11%	87.18%	46.44%	64.67%	56.42%	59.09%
Items per share
Cash flow per share ¹	10.8	15.13	12.08	13.29	14.23	11.41	12.1	7.842
Change	-	40.07%	-20.15%	10.05%	7.04%	-19.8%	6.02%	-35.18%
Dividend per Share ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Book Value Per Share ¹	42.49	50.4	58.42	70.06	67.69	68.81	75.1	78.34
Change	-	18.62%	15.92%	19.92%	-3.39%	1.66%	9.14%	4.31%
EPS ¹	7.2	7.6	9.48	9.22	0.2	4.525	5.895	6.913
Change	-	5.56%	24.74%	-2.74%	-97.83%	2,162.68%	30.26%	17.27%
Nbr of stocks (in thousands)	49,743	50,464	50,879	51,297	51,136	49,116	49,116	49,116
Announcement Date	17/02/21	16/02/22	22/02/23	14/02/24	19/02/25	-	-	-